Methods and compositions utilizing rad51
CA 2384733 A1 · Owner: Reddy, Gurucharan · Inventors: Reddy, Gurucharan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Herein methods are provided for determining the distribution of Rad51 foci in a first tissue type of a first individual and then comparing the distribution , to the distribution of Rad51 foci from a second normal tissue type from the first individual or a second unaffected individual. A difference in the distributions indicates that the first individual is at risk for a disease state which results in aberrant Rad51 foci. Preferred disease states include cancer and disease states associated with apoptosis. Also provided herein are methods for screening for modulators of Rad51 or homologues thereof and methods of using modulators of Rad51.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.